Table: Fuso Pharmaceutical -2017/18 parent results

Fuso Pharmaceutical Industries

10/05/2018 05:40

May 10 (Reuters)- 
          Fuso Pharmaceutical Industries Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           45.90           46.78          46.20        23.20    
               (-1.9 pct)      (+2.2 pct)     (+0.7 pct)    (+0.6 pct) 
  Operating      798 mln         656 mln          1.00       500 mln   
               (+21.7 pct)    (+121.2 pct)    (+25.2 pct)  (+53.1 pct) 
  Recurring      832 mln         642 mln        900 mln      500 mln   
               (+29.7 pct)    (+272.4 pct)    (+8.1 pct)   (+23.9 pct) 
  Net            970 mln         861 mln        600 mln      350 mln   
               (+12.6 pct)                    (-38.1 pct)  (+31.8 pct) 
  EPS          109.61 yen       95.86 yen      67.80 yen    39.55 yen  
  Ann Div       80.00 yen                      80.00 yen               
  -Q2 Div       40.00 yen       4.00 yen       40.00 yen               
  -Q4 Div       40.00 yen       40.00 yen      40.00 yen               
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T